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Background: The number of patients with eosinophilic chronic rhinosinusitis (ECRS) has been increasing
in recent years in Japan. In ECRS, nasal polyps recur immediately after endoscopic sinus surgery. The
molecular biological mechanism underlying the refractoriness of ECRS is unclear.
Methods: Whole-transcriptome analysis with next-generation sequencing (RNA-seq) was conducted to
investigate the molecular biological mechanism of ECRS. Real-time PCR, immunohistochemical staining,
and immunofluorescence staining were performed to validate the results of RNA-seq.
Results: RNA-seq analysis revealed that in the nasal polyps of ECRS, the levels of 3 transcripts were
elevated significantly and those of 7 transcripts were diminished significantly. Among the genes
encoding these transcripts, TRPV3 (transient receptor potential cation channel, subfamily V, member 3)
was identified as the only gene that is highly expressed in ECRS nasal polyps but this gene's expression
was not previously detected using DNA microarray analysis in peripheral blood eosinophils. TRPV3 is
newly identified here as a gene transcribed in ECRS. Our analysis also revealed that TRPV3 was highly
expressed in the infiltrating eosinophils and mucosal epithelium of the nasal polyps of ECRS, and further
that the more severe the refractoriness was after surgery, the higher the TRPV3 expression was in nasal
polyps.
Conclusions: TRPV3 might play a role in the refractoriness of ECRS. Additional studies are required to
evaluate the function of TRPV3 in ECRS.
Copyright © 2017, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Chronic rhinosinusitis (CRS) is a highly common chronic nasal
disease, and its symptoms include nasal purulent discharge, nasallogy e Head & Neck Surgery,
Faculty of Medical Science,
heiji-cho, Yoshida-gun, Fukui
ety of Allergology.
rgology. Production and hosting by Elsecongestion, and hyposmia. Several variants of CRS are presented
due to diverse underlying cellular and molecular mechanisms, and
the phenotypes of CRS are heterogeneous.1 CRS with nasal polyps
(CRSwNP) exhibits more intense eosinophilic infiltration and
presence of T-helper type 2 (Th2) cytokines in Western countries
than elsewhere; conversely, in East Asia, including in Japan,
neutrophil infiltration was previously predominant in CRSwNP.2
However, in recent years, the number of CRS cases with mucosal
eosinophilia has been increasing in Japan with the westernization
of eating habits and environments. In eosinophilic cases of CRSwNP,
nasal polyps recur immediately after endoscopic sinus surgeryvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Table 1
Patient characteristics.
ECRS Non-ECRS p value
Number of patients 5 5
Male/Female 2/3 4/1 n.s.y
Age 36 [29e52] 58 [57e59] 0.047*
Number of eosinophils
in NP (/HPF)
214.0 [155.0e249.0] 5.0 [5.0e6.0] 0.012*
Peripheral blood
eosinophils (%)
13.5 [10.6e13.6] 2.3 [1.8e3.2] 0.008**
JESREC score 15 [15e17] 9 [5e9] 0.010*
Representative values shown as medians with interquartile ranges (in brackets).
*p < 0.05, **p < 0.01, Wilcoxon rank-sum test.
ECRS, eosinophilic chronic rhinosinusitis; NP, nasal polyps; HPF, high-power field.
y c2 test.
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philic Chronic Rhinosinusitis Study (JESREC Study), a multicenter
retrospective study, we developed the diagnostic criterion and al-
gorithm for refractory eosinophilic CRS (ECRS). In the study, we
specifically noted the relationship between the level of eosinophilia
and the refractoriness of CRS: Our work showed that mucosal
eosinophilia of 70 eosinophils per high-power field (HPF: 400)
was significantly correlated with recurrence after ESS. The factors
significantly associated with ECRS recurrence were past history of
bronchial asthma, aspirin intolerance, nonsteroidal anti-
inflammatory drug intolerance, peripheral blood eosinophilia,
and ethmoid-dominant shadow in CT. According to these factors,
our algorithm classified CRS into 4 groups: non-ECRS, mild ECRS,
moderate ECRS, and severe ECRS. These groups were significantly
correlated with the rate of disease recurrence and refractoriness.3
Gene expression is an essential factor underlying cellular phe-
notypes, and a comprehensive catalog of gene transcripts, their
structures, and abundance facilitates the elucidation of how gene
expression determines phenotypic manifestations. The use of DNA
microarrays4,5 has served as the effective method of choice in gene-
expression studies because the microarrays can be used to
concurrently probe thousands of transcripts. Although this is a
high-throughput approach, it is likely to bias the results because of,
for example, the dependency on existing gene models and the
potential for cross-hybridization with probes featuring similar se-
quences. RNA sequencing (RNA-seq) performed using next-
generation sequencers is a comparatively new method for
analyzing gene expression, and it provides digital readouts for
mapping and quantifying transcriptomes.6,7 In RNA-seq, the
following procedure is used: a population of RNA is isolated and
transformed into a library of cDNA fragments with adaptors
attached, and the cDNA library is then sequenced to obtain short
sequences (typically 30e400 nucleotides long) and these short
reads are mapped to a reference genome or assembled de novo.
Subsequently, the expression levels of genes can be determined by
counting the number of reads that are aligned to their exons. RNA-
seq studies have revealed unknown aspects of transcriptomes,
including sequence information on not only exons, but also tran-
scriptional start sites, 50-untranslated regions, upstream open
reading frames, and alternative splicing events.6,8,9
Currently, the pathophysiological features of ECRS remain un-
established. Moreover, no reports have been published to date on
RNA-seq analysis of ECRS. In this study, we performed RNA-seq
analysis of the nasal polyps of CRS in order to reveal the tran-
scripts related to the refractoriness of ECRS. We compared and
analyzed the results of RNA-seq and microarray analyses, and then
identified and validated the transcripts that exhibited high
expression in ECRS.
Methods
Patients of RNA-seq
Nasal polyps were obtained from 10 CRS patients by means of
ESS performed at the University of Fukui Hospital, Japan. ECRS was
diagnosed based on the JESREC criterion and algorithm, which
divided the 10 CRS patients into ECRS and non-ECRS groups.3
Table 1 and Supplementary Table 1 list the details of the patients'
characteristics.
Total RNA isolation and rRNA depletion
Total RNA was isolated from nasal polyps by using an RNeasy®
Mini Kit (Qiagen, Hilden, Germany) according to themanufacturer's
protocol, and then 4e8 mg of each RNA sample was depleted ofrRNA by using a Ribo-Zero™ Gold kit (Epicentre Biotechnologies,
Madison, WI, USA) as per manufacturer instructions. RNA was
quantified using a NanoDrop1000 spectrophotometer (Thermo
Fisher Scientific, Waltham, MA, USA); RNA integrity was evaluated
through capillary electrophoresis performed using an Agilent 2100
Bioanalyzer, with RNA 6000 Pico chips (Agilent Technologies, Palo
Alto, CA, USA). Only total RNA samples with RNA Integrity Number
values10 of 7 were used for the next-generation sequencing
analysis.
Library preparation and next-generation sequencing
We used 300e450 ng of rRNA-depleted mRNAs for preparing
libraries by using a SOLiD™ Total RNA-Seq Kit (Life Technologies,
Grand Island, NY, USA) as per the manufacturer's instructions. The
complete library preparation protocol is available at http://tools.
invitrogen.com/content/sfs/manuals/cms_078610.pdf. The libraries
were subjected to emulsion PCR (SOLiD™ EZ Bead™ Emulsifier kit,
Life Technologies) to generate clonal DNA fragments on beads, and
this was followed by bead enrichment (SOLiD™ EZ Bead™ Enrich-
ment kit, Life Technologies). Enriched template beads were
sequenced on a SOLiD™ 5500xl system (Life Technologies) as single-
end, 75-bp reads. Library preparation, fragment-library protocols,
emulsion PCR, and all SOLiD-run parameters followed standard
Applied Biosystems protocols.
Mapping and processing of sequence data
The obtained sequences were aligned with UCSC human
genome 19 (hg19) by using Lifescope™ Genomic Analysis Solutions
version 2.5.1 (Life Technologies). Lifescope's default settings were
used: 40 alignments per read were allowed, with up to 2 mis-
matches per alignment.
The resulting aligned reads were analyzed further using Avadis®
NGS v1.4.1 (Strand Scientific Intelligence, San Francisco, CA, USA).
Avadis NGS assembled the aligned reads into transcripts, either
with or without a reference genome (UCSC transcripts), and re-
ported the expression of those transcripts in “Reads Per Kilobase of
exon per Million mapped reads,” or RPKM, which is an expression
of the relative abundance of transcripts.6 The t test was used to
determine differential expression of transcripts in non-ECRS and
ECRS samples. The results of multiple tests were corrected using
the BenjaminieHochberg false-discovery rate.11
Quantitative real-time RT-PCR (qRT-PCR)
RNA was isolated from nasal polyps obtained from 40 CRS pa-
tients except for those of RNA-seq. The polyps were obtained by
means of ESS performed at the University of Fukui Hospital, Japan.
Fig. 1. Flowchart of differential-expression analysis. Differential-expression analysis
was performed on the 19,932 transcripts obtained after excluding low-expression
transcripts from all samples. Sex-chromosome genes were also excluded from the
analysis. Analysis threshold was set as >5-fold. The positive and negative values reflect
high and low expression in ECRS, respectively. N, number of transcripts.
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We performed qRT-PCR by using the TaqMan® Universal Master
Mix and Gene Expression Kit (Applied Biosystems, Foster City, CA,
USA) according to the manufacturer's instructions. Primer and
probe set for TRPV3 (Hs00376854_m1) was purchased from
Applied Biosystems.
Immunohistochemical staining
Nasal polyp specimens were collected from 80 CRS patients
except for those of RNA-seq. The polyps were obtained by means of
ESS performed at the University of Fukui Hospital, Japan. ECRS was
diagnosed based on the JESREC criterion and algorithm. The spec-
imens were fixed in neutral buffered formalin (10% (v/v) formalin in
water, pH 7.4) and embedded in paraffin wax. Immunohistochem-
ical staining was performed on 4-mm-thick sections by using a
TRPV3-specific antibody (SigmaeAldrich, St. Louis, MO, USA). The
number of positive cells of TRPV3 in themucosal epithelial cells was
counted at HPF (400) in the three densest areas, and the mean
number of positive cells was calculated. Histological examinations
were performed unaware of the clinical data. Images from immu-
nofluorescence slides were obtained with an Olympus BX53
inverted research microscope and were collected by using cell-
Sens® Standard software (Olympus, Tokyo, Japan).
Immunofluorescence staining
Nasal polyp specimens were collected from ECRS patients. Pe-
ripheral bloodwas collected from ECRS patients and normal control
subjects. The nasal polyp specimens were fixed in neutral buffered
formalin (10% (v/v) formalin in water, pH 7.4) and embedded in
paraffin wax. Eosinophils were isolated from peripheral blood
mononuclear cells by using MACS® Cell Separation system (Milte-
nyi Biotech, Bergisch Gladbach, Germany) and were cytospinned
onto glass slides. To stain TRPV3 and ECP (eosinophil cationic
protein), samples were incubated with TRPV3-specific antibody
produced in mouse (SigmaeAldrich) and ECP-specific antibody
produced in rabbit (Bioss Antibodies, Woburn, MA, USA) at the
dilution mentioned above overnight at 4 C. After washing with
PBS, samples were incubated with Alexa Fluor® 594-conjugated
goat anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) and Alexa
Fluor® 488-conjugated goat anti-rabbit IgG (Invitrogen) for 1 h at
room temperature in the dark. After final washing with PBS, cov-
erslips weremounted onto slides by using SlowFade®Gold Antifade
Mountant with DAPI (Thermo Fisher Scientific, Waltham, MA, USA).
Images from immunofluorescence slides were obtained with an
Olympus BX53 inverted research microscope and were collected by
using cellSens® Standard software (Olympus).
Microarray analysis
Microarray assays were performed using the same samples as
those used for RNA-seq. We performed microarray assays by using
the Illumina BeadArray single-color platform (Illumina, San Diego,
CA, USA). In the assay, cRNA was synthesized by using an Illumina
TotalPrep RNA Amplification Kit (Ambion, Austin, TX, USA) ac-
cording to the manufacturer's instructions: 500-ng aliquots of total
RNA were reverse-transcribed into first- and second-strand cDNA,
and then transcribed to acquire biotin-labeled cRNA. A total of
750 ng of biotin-labeled cRNAwas hybridized to each HumanHT-12
v4 Expression BeadChip Kit (Illumina) at 58 C for 20 h. The hy-
bridized BeadChip was washed and labeled with streptavidin-Cy3
(GE Healthcare, Waukesha, WI, USA) and then scanned with the
Illumina BeadStation 500 System (Illumina).We prepared duplicate
samples from the same cRNA sample for each BeadChip in order toassess whether the assay performed adequately. The correlation
coefficients for replicating RNAs were 0.995e0.998 (r2).
RNA-seq data were compared with microarray data. All data
were log2-normalized.
Statistical analysis
All data are reported as means ± standard deviation unless
otherwise noted. Differences between groups were analyzed by
performing one-way ANOVA with Tukey post hoc testing or Stu-
dent's t test. Correlations were assessed by using the Pearson cor-
relation. A p value or a corrected p value (“q value”) of <0.05 was
considered statistically significant. Besides using the statistical
tools embedded in Avadis NGS, we performed additional statistical
analyses by using R version 2.13.1 for MacOSX GUI 1.40-devel
Leopard build 64-bit (R-project, http://www.r-project.org/) and
Prism 5.0b for MacOS (MDF, Tokyo, Japan).
Ethical issue
All patients provided informed consent, and the protocol and
consent forms governing the procedures for the study were
approved by the Research Ethics Committee of the University of
Fukui (#20120076).
Results
Alignment results
In the 110 ± 7.1 million-read dataset per sample, 58 ± 8.1% of the
reads aligned to the human genome reference hg19. Although <3%
of the human genome is composed of exons, 62 ± 2.8% of our
uniquely mapped reads overlap gene code exons. These results
confirm that our RNA samples are highly enriched for exonic
sequences.
Expression analysis
To estimate the expression levels of genes in nasal polyps, we
used all of the obtained sequence reads (Fig. 1). A gene's expression
level is given by the sum of the RPKM values of its isoforms. The
T. Tokunaga et al. / Allergology International 66 (2017) 610e616 613distribution of RPKM values was skewed, and the median RPKM
values of non-ECRS and ECRS were 33.8 and 32.5, respectively. A
total of 36,579 transcripts from the nasal polyps mapped to the
reference transcriptome hg19 from UCSC, and 19,932 analyzable
transcripts were selected after excluding all of the low-expression
transcripts from all samples. Differential-expression analysis was
performed on these 19,932 transcripts, and 12 transcripts were
found to differ in a statistically significant manner by >5 times
between ECRS and non-ECRS. The 12 transcripts included 10 known
and 2 previously unidentified transcripts. Details of the transcripts
are included in Table 2.
We found that 3 transcripts were expressed at elevated levels in
the nasal polyps of ECRS, and among these, the transcript for TRPV3
(transient receptor potential cation channel, subfamily V, member
3) was the only transcript whose expression was not detected in
peripheral eosinophils by using microarray analysis.12TRPV3 expression
Real-time PCR and immunohistochemical staining were per-
formed to validate the RNA-seq results: Real-time PCR analysis,
performed in 20 non-ECRS cases and 20 ECRS cases, revealed that
TRPV3 was expressed at significantly higher levels in the nasal
polyp of ECRS than in that of non-ECRS. Expression levels of TRPV3
mRNA per nanogram of total RNA were 45.2 ± 61.9 copies for non-
ECRS and 640.1 ± 819.4 copies for ECRS (Fig. 2A). Moreover,
immunohistochemistry were performed in 80 patients: 20 cases of
non-ECRS, 20 cases of mild ECRS, 20 cases of moderate ECRS, and 20
cases of severe ECRS. Immunohistochemistry results showed that
TRPV3 was highly expressed in the infiltrating cells and mucosal
epithelium of the nasal polyps of ECRS (Fig. 2B). To investigate
whether the infiltrating TRPV3þ cells are eosinophils or not,
immunofluorescence were performed in nasal polyps. Immuno-
fluorescence results showed that ECP was highly expressed in the
infiltrating TRPV3þ cells of the nasal polyps of ECRS (Fig. 2C). These
results suggest that the infiltrating TRPV3þ cells were eosinophils.
Moreover, immunofluorescence staining were performed to
investigate whether TRPV3 is expressed in peripheral eosinophils
or not. TRPV3 was highly expressed in peripheral eosinophils of
both ECRS patients and normal control subjects (Fig. 2D). These
results were inconsistent with the result of microarray analysis.12Association between the refractoriness of ECRS and TRPV3
expression
Comparison of the expression in the 4 groups identified using
the JESREC algorithm showed that the more severe theTable 2
Differentially expressed transcripts.
Gene Locus Gene type Fold-change q value Eosinophily
High expression in ECRS (Fold-change > 5.0)
SIGLEC8 chr 19 Protein-coding 7.76 0.047 P
TRPV3 chr 17 Protein-coding 5.81 0.045 A
GPR97 chr 16 Protein-coding 5.56 0.047 P
Low expression in ECRS (Fold-change < ¡5.0)
LOC285141 chr 2 Protein-coding 5.41 0.045 N/A
HABP2 chr 10 Protein-coding 6.22 0.045 A
CCDC153 chr 11 Protein-coding 6.59 0.046 N/A
LOC100652764 chr 1 miscRNA 6.79 0.030 N/A
SCG3 chr 15 Protein-coding 7.57 0.030 A
LRRC18 chr 10 Protein-coding 9.98 0.046 A
C1orf129 chr 1 Protein-coding 11.47 0.030 N/A
P, present; A, absent; N/A, not applicable; ECRS, eosinophilic chronic rhinosinusitis.
y Expression profile in peripheral eosinophils determined through microarray
analysis by Saito et al.12refractoriness was, the higher the level of TRPV3 expression was in
epithelial cells of nasal polyps. The numbers of positive cells of
TRPV3 expression were 16.2 ± 10.9/HPF for non-ECRS, 33.7 ± 20.6/
HPF for mild ECRS, 68.4 ± 29.9/HPF for moderate ECRS, and
52.9 ± 25.2/HPF for severe ECRS (Fig. 3A). Correlation between
TRPVþ epithelial cells and infiltrating eosinophils was only a
modest, and thus higher level of TRPV3 expression of epithelial
cells was independent of an influence of the numbers of infiltrating
eosinophils on the refractoriness of ECRS (Fig. 3B).
Discussion
In this study, we used next-generation sequencing to perform
whole-transcriptome analysis on the nasal polyps of ECRS. This is
the first report of a study of this type. We focused on TRPV3, the
gene specifically expressed in the nasal polyps of ECRS. ECRS is
often associatedwith bronchial asthma. TRPA1 and TRPM8, another
subtypes of transient receptor potential (TRP) channel family, may
play important roles in the development of bronchial asthma.
TRPA1 is expressed in lung fibroblasts,13 and it is linked to airway
inflammation.14 TRPM8 is expressed in autonomic afferent nerves
innervating the broncho-pulmonary system, which may increase
airway resistance with neural activation. Activated TRPM8 may be
of relevance to aggravation of bronchial asthma.15 However, there is
no report that TRPV3 is expressed in bronchial tissues of asthma.
TRPV3 may be a specific molecule in ECRS. TRPV3 has been widely
investigated in skin keratinocytes, and Yamamoto-Kasai et al. re-
ported that TRPV3 expressed in these cells contributes to the
regulation of dendritic cells in atopic dermatitis.16 However, the
function of TRPV3 in the nasal mucous epithelium remains to be
clarified.
The TRP channel family represents a group of temperature-
sensitive ion channels located on the plasma membrane; these
channels contain 6 transmembrane domains and cytosolic N- and
C-terminal tails. In recent years, proteins of the TRP channel family,
including TRPV1 (capsaicin receptor), have attracted considerable
research attention as potential targets for drug development. TRP
channels are activated by several chemicals, osmotic stimuli, tem-
perature stimuli, and neuropathic pain, and thus the channels
function as transducers that convert environmental information
into electronic signals through the flow of cations into the intra-
cellular fluid. Epithelial cells harboring specific activated TRP
channels release inflammatory substances such as prostaglandin
E217 and other cytokines. Furthermore, TRPV3 regulates intracu-
taneous nitric oxide (NO) synthesis through nitrite reduction
independently of NO synthase.18 A randomized control trial study
of CRS patients demonstrated that in patients treated with capsa-
icin, nasal polyps were significantly smaller than in control pa-
tients.19 These results suggest that the TRP channel family might
contribute to inflammation, even if it occurs in the airway.20
TRPV3 is located at chromosome 17p13 and is immediately next
to TRPV1, the gene that encodes the capsaicin receptor. The TRPV3
gene contains 18 exons and encodes a Ca2þ-permeable nonselective
cation channel that is broadly expressed in skin keratinocytes and
oral and nasal mucous epithelia. TRPV3 belongs to the group of
warm-sensitive TRP channels whose activation-temperature
thresholds range from 31 to 39 C.21 Furthermore, several chemi-
cal activators for TRPV3 have been identified, and among these, 2-
aminoethoxydiphenyl borate, which was first described as an in-
hibitor of inositol trisphosphate receptors,22 is the most frequently
reported activator.23,24 Synergism between chemical ligands and
temperature and between structurally different chemical ligands is
generally observed for thermosensitive TRPV channels; this phe-
nomenon has been described in detail and discussed in a recent
review.25 Other reported TRPV3 activators include camphor,26,27
Fig. 2. TRPV3 expression in nasal polyps. (A) Total RNAwas extracted from the nasal polyps of patients with CRSwNP, and TRPV3 expression was analyzed using real-time PCR. Lines
and error bars represent means and standard deviation. **p < 0.01. (B) Immunohistochemical staining for TRPV3 in nasal polyps from non-ECRS (a) and ECRS (b). Upper row shows
low-magnification (100). Lower row shows high-magnification (400). Nasal polyps of ECRS showed more intense TRPV3 staining in epithelial tissues and the infiltrating eo-
sinophils (arrows) than did the polyps of non-ECRS. (C) Immunofluorescence staining for TRPV3 and ECP in nasal polyps. Upper row shows non-ECRS. Lower row shows ECRS. Both
TRPV3 and ECP were positive in the infiltrating cells of ECRS. (D) Immunofluorescence staining for TRPV3 and ECP in peripheral eosinophils of ECRS patients. The same results were
obtained with peripheral eosinophils of normal control subjects (figure not shown).
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recognized as flavoring components or skin intensifiers.30,31 The
effect of these components on nasal symptom was examined in
several studies. Schriever et al. showed that subjective nasal
patency of patients with olfactory dysfunction increased with oral
menthol application.32Whereas these several natural and synthetic
materials have been described as TRPV3 activators, the intrinsic
activators of TRPV3 remain undefined. However, farnesyl pyro-
phosphate, an intermediate in the steroid-hormone biosynthesis
pathway, has been shown to strongly and specifically activate
TRPV3.33
TRPV3 regulates diverse functions in skin keratinocyte,
including temperature sensing, skin barrier formation, wound
healing, hair growth, and itch and pain perceptions.34 Cheng et al.
showed that keratinocyte TRPV3 forms a signaling complex with
transforming growth factor-a (TGF-a) and epidermal growth factor
receptor (EGFR); EGFR activation leads to enhanced TRPV3 channel
activity, which in turn stimulates TGF-a release.35 TGF-a expression
in the submucosal tissue was markedly higher in ECRS patientsthan in non-ECRS patients. Furthermore TGF-a synergized with
tumor necrosis factor-a and thereby upregulated mucin 5AC
expression in human epithelial cells through the extracellular
signal-regulated kinase signaling pathway.36 If TRPV3 forms a
signaling complex with TGF-a/EGFR in the nasal polyps of ECRS,
TRPV3 might play a role in mucous hypersecretion, mucous
vascularization, and the proliferation of glandular cells and fibro-
blasts; this might be deeply involved in the recurrence and
refractoriness of ECRS. The results of our study indicate that TRPV3
is expressed in the nasal polyps of ECRS but the function of TRPV3
in the nasal polyps remains unknown. Further investigation is
required to evaluate the function of TRPV3 in the nasal polyps of
ECRS. A TRPV3 antagonist has been created37 and moved into
Phase-II clinical trials for the treatment of neuropathic pain, and
additional studies on TRPV3 agonists and antagonists might un-
cover new therapeutic opportunities for ECRS.
We compared our RNA-seq data with the microarray measure-
ments performed on the same samples. The numbers of transcripts
detected by microarray and RNA-seq were 34,692 and 19,932,
Fig. 3. (A) Number of TRPV3þ cells in nasal polyps from CRSwNP classified by the
JESREC algorithm. Lines and error bars represent means and standard deviation.
Expression level was correlated with the refractoriness of CRSwNP.
Magnification: 400. *p < 0.05; **p < 0.01; ***p < 0.001. HPF, High-power field. (B)
Correlation between the number of TRPV3þ epithelial cells and infiltrating eosinophils.
Person correlation coefficients: R ¼ 0.27 (p ¼ 0.017).
T. Tokunaga et al. / Allergology International 66 (2017) 610e616 615respectively. Among them, the number of transcripts identified by
both methods was 16,862. The RNA-seq and microarray results
were strongly correlated for gene-expression levels obtained with
log-transformed FC values (R ¼ 0.75, p < 0.001) (Supplementary
Fig. 1), and, furthermore, were comparable to results reported by
others (R ¼ 0.67 and 0.80).38,39 In the case of TRPV3, a significant
difference in expression was not detected using microarray anal-
ysis, but was confirmed using RNA-seq. Furthermore, real-time PCR
and immunofluorescence staining showed high expression of
TRPV3 in both nasal polyps and peripheral eosinophils. On the
other hand, Saito et al. performed the microarray analysis of pe-
ripheral eosinophils, which could not detect high expression of
TRPV3.12 They used the GeneChip® Human Genome U133A probe
array (Affymetrix, Santa Clara, CA, USA), whereas we used the
HumanHT-12 v4 Expression BeadChip Kit (Illumina). Neither of the
two arrays could detect high expression of TRPV3. This discrepancy
between microarray and RNA-seq may be due to an inappropriate
probe hybridized with TRPV3 in microarray kit. Sensitivity of probe
is defined by how strongly a probe binds to its target sequence. It
affects the strength of the signal read from the microarray.40
The rate of concordance between microarray data and RNA-seq
data has been investigated in several preceding studies. For
instance, Sultan et al. measured gene expression differencebetween two human cell lines (B cells and embryonic kidney cells)
and reported that the log-transformed FC values obtained using the
two methods significantly correlated (R ¼ 0.88).41 Wang et al.42
reviewed a comparison of the data from two studies that exam-
ined the yeast transcriptome by using microarrays43 and RNA-seq.7
Wang et al. found that the correlation was very low
(R ¼ 0.099e0.177) at low transcript levels in RNA-seq, but
comparatively higher (R¼ 0.509) at moderate transcript levels. This
might reflect the narrower dynamic range of microarrays than
RNA-seq. Fu et al.38 compared three methods employed for gene
expression analysis of human brain samples: use of RNA-seq,
microarrays, and mass spectrometry. The correlation coefficient
between the microarray data and the RNA-seq data ranged from
0.51 to 0.67, which depend on the type of samples. Moreover,
protein abundances quantified using mass spectrometry, which
were converted into the equivalent levels of mRNAs, correlated
more strongly for the RNA-seq data than for the microarray data.
On the other hand, Malone et al.44 showed that high correlations
were noted when directly matching microarray intensity values
with RNA-seq read counts, although lower correlations were found
when matching FC values. A high concordance between RNA-seq
data and microarray data was detected in human T cells39 and in
a rat pain model45 as well. The different strengths of correlations
reported by these studies indicate a lack of integrity when assessing
the level to which the two methods apply. Here, we report an
extent of correspondence between RNA-seq data and microarray
data that agrees with the aforementioned reports. The correlation
of log-transformed FC values was high.
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